Is there an Indian generic version of lapatinib?
Lapatinib (Lapatinib) is an oral anti-cancer drug that belongs to a category of targeted therapy drugs. Its main function is to inhibit the activation of two receptor proteins, human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR), thereby preventing the growth and spread of breast cancer and some other malignant tumors.
There is an Indian generic version of lapatinib, and the price is around a few hundred yuan. Lapatinib is already on the market in China, but it has not yet been included in medical insurance. Patients can purchase it domestically at a price of around 5,000 to 6,000 yuan. Please consult the local hospital pharmacy for specific prices. There are original lapatinib drugs and generic drugs abroad. The original drug is cheaper than the original drug in Türkiye, which costs more than 2,000 yuan. Generic drugs include Indian generic drugs and Bangladeshi generic drugs, and the price is around a few hundred yuan. The ingredients of domestic original drugs, foreign original drugs and generic drugs are basically the same.

Lapatinib is commonly used to treat HER2positive breast cancer, a subtype of breast cancer characterized by overexpression or abnormal activation of the HER2 receptor on tumor cells. HER2positive breast cancer is generally more aggressive than HER2negative breast cancer, but lapatinib can help suppress the growth of this type of breast cancer and improve patients' survival rates.
The mechanism of lapatinib is to bind to HER2 and EGFR receptors and inhibit their activity. This helps reduce signaling, hindering cancer cell proliferation and survival. Lapatinib is often used as part of a breast cancer treatment regimen, either alone or in combination with other drugs, depending on the patient's condition and the recommendations of the doctor.
However, the use of lapatinib may be associated with some side effects, such as diarrhea, skin rash, nausea, vomiting, etc. Therefore, before using this medication, doctors will conduct a thorough evaluation to ensure that the patient is suitable for this treatment and closely monitor the patient's response.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)